Myeloid-derived suppressor cells in tumor-induced T cell suppression and tolerance

Paolo Serafini, Vincenzo Bronte

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations

Abstract

Tumor development is often associated with a deep alteration of normal myelopoiesis, leading to a progressive accumulation of various cellular elements, belonging to myelomonocytic lineage, in the tumor bed, in the blood, and in both primary and secondary lymphoid organs. This heterogeneous pool of cells expresses, in the mouse, the common markers CD11b and Gr-1 (Ly6C/G) and is endowed with the ability to suppress antigen and/or polyclonal-driven T cell immune response. These cells, named myeloid-derived suppressor cells (MDSCs), are mobilized from hematopoietic organs by cytokines and other factors produced by the tumors, as well as by strong activation of the immune system, and have a profound influence on the outcome of the T cell-dependent immune responses. MDSCs can restrain T cell function directly in an antigen-independent manner; however, in vivo, MDSCs can also process and present tumor-associated antigen and can lead to T cell tolerance in an antigen-specific manner. Furthermore, MDSCs seem to be key players in tumor-induced suppressive network that includes T regulatory (Treg) cells, inhibitory natural killer T (NKT) cells, mast cells, Th17, as well as effector T cells. The importance of MDSCs in human malignancies has been demonstrated in recent years and new approaches targeting their suppressive/tolerogenic action are currently being tested in both preclinical model and clinical trials.

Original languageEnglish (US)
Title of host publicationTumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
PublisherSpringer New York
Pages99-150
Number of pages52
Volume9781489980564
ISBN (Print)9781489980564, 1489980555, 9781489980557
DOIs
StatePublished - Feb 1 2014

Keywords

  • Clinical trials
  • Human myeloid derived suppressor cells
  • MDSC phenotype
  • Mechanisms of action
  • Mouse myeloid derived suppressor cells
  • Tumor derived factors
  • Tumor progression

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Myeloid-derived suppressor cells in tumor-induced T cell suppression and tolerance'. Together they form a unique fingerprint.

  • Cite this

    Serafini, P., & Bronte, V. (2014). Myeloid-derived suppressor cells in tumor-induced T cell suppression and tolerance. In Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal (Vol. 9781489980564, pp. 99-150). Springer New York. https://doi.org/10.1007/978-1-4899-8056-4_4